Ambrisentan: A guide to its use in pulmonary arterial hypertension classified as WHO functional class II or III

被引：0
|
作者：
Behr J. [1 ]
Lyseng-Williamson K.A. [2 ]
机构：
[1] Division of Pulmonary Diseases, Department of Internal Medicine i, University of Munich, Munich
[2] Adis, A Wolters Kluwer Business, Auckland
来源：
Drugs & Therapy Perspectives | 2011年 / 27卷 / 1期
关键词：
Ambrisentan; therapeutic use; Endothelin-receptor-antagonists; Pulmonary-hypertension; treatment; Treatment-algorithms;
D O I：
10.2165/11205380-000000000-00000
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1 / 8
页数：7
相关论文
共 50 条
  • [41] Optimal Use of Treprostinil in Pulmonary Arterial Hypertension A Guide to the Correct Use of Different Formulations
    Skoro-Sajer, Nika
    DRUGS, 2012, 72 (18) : 2351 - 2363
  • [42] Factors prohibiting progression to prostanoid therapy in patients with pulmonary arterial hypertension and CTEPH who remain in functional class III or above despite maximal oral therapy
    Nashat, H.
    Harries, C.
    Parfitt, L.
    Alonso-Gonzalez, R.
    Price, L.
    Gatzoulis, M.
    Wort, S. J.
    Dimopoulos, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 565 - 565
  • [43] The Comparison of the WHO Functional Classification and Exercise Capacity in Patients with Pulmonary Arterial Hypertension
    Irisawa, Hiroshi
    Watanabe, Hiroshi
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S145 - S145
  • [44] Riociguat: A Review of Its Use in Patients with Chronic Thromboembolic Pulmonary Hypertension or Pulmonary Arterial Hypertension
    Garnock-Jones, Karly P.
    DRUGS, 2014, 74 (17) : 2065 - 2078
  • [45] Riociguat: A Review of Its Use in Patients with Chronic Thromboembolic Pulmonary Hypertension or Pulmonary Arterial Hypertension
    Karly P. Garnock-Jones
    Drugs, 2014, 74 : 2065 - 2078
  • [46] Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Sohita Dhillon
    Drugs, 2014, 74 : 1495 - 1507
  • [47] Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Dhillon, Sohita
    DRUGS, 2014, 74 (13) : 1495 - 1507
  • [48] Functional Class and Targeted Therapy Are Related to the Survival in Patients with Pulmonary Arterial Hypertension
    Park, Yae Min
    Chung, Wook-Jin
    Choi, Deok Young
    Baek, Han Joo
    Jung, Sung Hwan
    Choi, In Suck
    Shin, Eak Kyun
    YONSEI MEDICAL JOURNAL, 2014, 55 (06) : 1526 - 1532
  • [49] Use of Pulmonary Arterial Hypertension-Specific Therapy in Non-WHO Group I Pulmonary Hypertension
    Shujaat, Adil
    Bellardini, Jason
    Cury, James D.
    Bajwa, Abubakr A.
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (01) : 51 - 57
  • [50] Association of HLA Class II Genes with Idiopathic Pulmonary Arterial Hypertension in Koreans
    Sung-Ho Yoon
    Heung-Bum Oh
    Hyun-Kuk Kim
    Suk-Chan Hong
    Yeon-Mok Oh
    Dong Soon Lee
    Sang-Do Lee
    Lung, 2007, 185 : 145 - 149
12345